fluorouracil has been researched along with snx 2112 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Liu, Q; Liu, Y; Wang, S; Wang, X; Wang, Y; Yan, H; Zhang, L; Zhang, Y; Zheng, K | 1 |
1 other study(ies) available for fluorouracil and snx 2112
Article | Year |
---|---|
Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Drug Antagonism; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; G2 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 4 or More Rings; HSP90 Heat-Shock Proteins; Humans; Matrix Metalloproteinases; Tumor Cells, Cultured | 2015 |